CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2005; 55:31-44
doi: 10.3322/canjclin.55.1.31
© 2005 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
QUIZ 1 WORKSHEET: ACS Guidelines for the Early Detection of Ca...
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. A.
Right arrow Articles by Eyre, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. A.
Right arrow Articles by Eyre, H. J.

American Cancer Society Guidelines for the Early Detection of Cancer, 2005

Robert A. Smith, PhD, Vilma Cokkinides, PhD and Harmon J. Eyre, MD


Dr. Smith is Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Program Director, Risk Factor Surveillance, Department of Epidemiology and Research Surveillance, American Cancer Society, Atlanta, GA.
Dr. Eyre is Executive Vice President for Research and Medical Affairs, American Cancer Society, and Editor-in-Chief of CA, Atlanta, GA.

Each January, the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection, including guideline updates, emerging issues that are relevant to screening for cancer, and a summary of the most current data on cancer screening rates for US adults. In 2004, there were no updates to ACS guidelines. In this article, we summarize the current guidelines, discuss recent evidence and policy changes that have implications for cancer screening, and provide an update of the most recent data pertaining to participation rates in cancer screening by age, gender, and insurance status from the Centers for Disease Control and Prevention’s Behavioral Risk Factor Surveillance System.




This article has been cited by other articles:


Home page
J Med ScreenHome page
J. P Stimpson, F. A Wilson, and C. A Reyes-Ortiz
Influence of number of children on cancer screening among adults in the United States
J Med Screen, December 1, 2009; 16(4): 170 - 173.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
S. V. Hudson, P. Ohman-Strickland, J. M. Ferrante, G. Lu-Yao, A. J. Orzano, and B. F. Crabtree
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
J Am Board Fam Med, May 1, 2009; 22(3): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
Ann Fam MedHome page
T. Wilkins, B. LeClair, M. Smolkin, K. Davies, A. Thomas, M. L. Taylor, and S. Strayer
Screening Colonoscopies by Primary Care Physicians: A Meta-Analysis
Ann. Fam. Med, January 1, 2009; 7(1): 56 - 62.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
L. Vidal, W. G. LeBlanc, K. E. McCollister, K. L. Arheart, K. Chung-Bridges, S. Christ, A. J. Caban-Martinez, J. E. Lewis, D. J. Lee, J. Clark III, et al.
Cancer Screening in US Workers
Am J Public Health, January 1, 2009; 99(1): 59 - 65.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem., December 1, 2008; 54(12): e11 - e79.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Huynh, V. C. Ngo, J. Fargnoli, M. Ayers, K. C. Soo, H. N. Koong, C. H. Thng, H. S. Ong, A. Chung, P. Chow, et al.
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
Clin. Cancer Res., October 1, 2008; 14(19): 6146 - 6153.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Shapiro, L. C. Seeff, T. D. Thompson, M. R. Nadel, C. N. Klabunde, and S. W. Vernon
Colorectal Cancer Test Use from the 2005 National Health Interview Survey
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1623 - 1630.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. B. Bach, G. A. Silvestri, M. Hanger, and J. R. Jett
Screening for Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 69S - 77S.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. P. Kerfoot, E. F. Holmberg, E. V. Lawler, E. Krupat, and P. R. Conlin
Practitioner-Level Determinants of Inappropriate Prostate-Specific Antigen Screening
Arch Intern Med, July 9, 2007; 167(13): 1367 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. B. Dailey, S. V. Kasl, T. R. Holford, and B. A. Jones
Perceived Racial Discrimination and Nonadherence to Screening Mammography Guidelines: Results from the Race Differences in the Screening Mammography Process Study
Am. J. Epidemiol., June 1, 2007; 165(11): 1287 - 1295.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and H. J. Eyre
Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects
CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104.
[Abstract] [Full Text] [PDF]


Home page
radtechHome page
T. G. ODLE
Breast Ultrasound
Radiol. Technol., January 1, 2007; 78(3): 222M - 242M.
[Abstract] [Full Text] [PDF]


Home page
J Gerontol A Biol Sci Med SciHome page
M. T. Heflin, K. I. Pollak, M. N. Kuchibhatla, L. G. Branch, and E. Z. Oddone
The Impact of Health Status on Physicians' Intentions to Offer Cancer Screening to Older Women
J Gerontol A Biol Sci Med Sci, August 1, 2006; 61(8): 844 - 850.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Balasubramani, B. W. Day, R. E. Schoen, and R. H. Getzenberg
Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon Cancer
Cancer Res., January 15, 2006; 66(2): 763 - 769.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Calvocoressi, M. Stolar, S. V. Kasl, E. B. Claus, and B. A. Jones
Applying Recursive Partitioning to a Prospective Study of Factors Associated with Adherence to Mammography Screening Guidelines
Am. J. Epidemiol., December 15, 2005; 162(12): 1215 - 1224.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. Crandall and J. P. Pregler
Update in Women's Health
Ann Intern Med, December 6, 2005; 143(11): 823 - 829.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
E. A. Boatwright, B. S. Tozer, D. P. Verma, J. E. Blair, A. P. Mayer, and J. A. Files
Health Care Maintenance in Female Adolescents
Mayo Clin. Proc., December 1, 2005; 80(12): 1641 - 1650.
[Abstract] [PDF]


Home page
ThoraxHome page
W Hamilton, T J Peters, A Round, and D Sharp
What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study
Thorax, December 1, 2005; 60(12): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Diehl, M. Li, D. Dressman, Y. He, D. Shen, S. Szabo, L. A. Diaz Jr, S. N. Goodman, K. A. David, H. Juhl, et al.
Detection and quantification of mutations in the plasma of patients with colorectal tumors
PNAS, November 8, 2005; 102(45): 16368 - 16373.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. B. Thomas and J. L. Abbruzzese
Opportunities for Targeted Therapies in Hepatocellular Carcinoma
J. Clin. Oncol., November 1, 2005; 23(31): 8093 - 8108.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
O. J. Finn
Immune Response as a Biomarker for Cancer Detection and a Lot More
N. Engl. J. Med., September 22, 2005; 353(12): 1288 - 1290.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by American Cancer Society.